Celcuity Target Price

Where could CELC trade next? Consensus target price: $160.

Get informed when a big investor buys or sells

+ Follow

Share Price

$96.43

Average Target Price

$164.94

71% upside

16 analysts in the last 4 months

High: $189 | Low: $140

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-17	GuggenheimBrad Canino	$175	81.5% upside
2026-08-14	NeedhamGil Blum	$140	45.2% upside
2026-07-15	Craig-Hallum	$178	84.6% upside
2026-07-15	H.C. Wainwright	$155	60.7% upside
2026-06-03	Craig-Hallum	$171	77.3% upside
2026-06-03	H.C. Wainwright	$145	50.4% upside
2026-06-03	Wells FargoEva Fortea Verdejo	$166	72.1% upside
2026-06-02	Leerink PartnersAndrew Berens	$155	60.7% upside
2026-05-28	Macquarie	$160	65.9% upside
2026-05-18	H.C. WainwrightSwayampakula Ramakanth	$185	91.8% upside
2026-05-15	Wells Fargo	$183	89.8% upside
2026-05-04	Craig-HallumChase Knickerbocker	$189	96% upside
2026-05-04	GuggenheimBrad Canino	$165	71.1% upside
2026-05-04	Needham	$157	62.8% upside
2026-05-04	Stifel NicolausStephen Willey	$150	55.6% upside
2026-05-04	H.C. Wainwright	$165	71.1% upside
2026-03-26	Craig-Hallum	$141	46.2% upside
2026-03-12	Wolfe ResearchKalpit Patel	$110	14.1% upside
2026-03-10	NeedhamGil Blum	$122	26.5% upside
2025-12-12	Wells Fargo	$126	30.7% upside
2025-10-22	H.C. WainwrightSwayampakula Ramakanth	$77	20.1% downside
2025-10-20	Needham	$95	1.5% downside
2024-08-15	Stifel NicolausBradley Canino	$39	59.6% downside
2024-05-30	Stifel NicolausBradley Canino	$40	58.5% downside
2024-03-28	NeedhamGil Blum	$24	75.1% downside

Celcuity (CELC) FAQ

Celcuity's target price stands at $160. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $160 for CELC implies 71.0% upside versus today's price ($96.43). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Celcuity's target price evolved across reporting periods, while the comparison chart places CELC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Celcuity's reading of $160 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.